Fresenius Kabi adds lacosamide injection to its product portfolio. The lacosamide injection, USP is supplied in a 200 mg per 20 mL single-dose vial presentation for intravenous (IV) use.

• Fresenius Kabi USA
  For more information, visit pppmag.com/info